Maternal antibodies do not interfere with VEPURED® efficacy

Home Knowledge Maternal antibodies do not interfere with VEPURED® efficacy

Maternal antibodies do not interfere with VEPURED® efficacy

VEPURED® is a vaccine developed to protect piglets against edema disease (ED) from 2 days of age, even when maternally derived antibodies (MDAs) could still be present.

About this article

Appeared in

ESPHM Congress, 2017

Date

Oct 23, 2017

Authors

Simon-Grifé, M.; Mallorquí, J.; Ferrer-Soler, L.; Roca, M.; Saün, X.; Sitjà, M.

Summary

VEPURED® efficacy was clearly demonstrated in the presence of field representative MDAs.

Related products

Share this on